Omnicell, Inc. (OMCL) vs Teladoc Health, Inc. (TDOC)
Omnicell, Inc. and Teladoc Health, Inc. are both Health Information Services companies. Omnicell, Inc. is the larger, with a market value of $1.5B against $1.1B — 1.3× the size. Teladoc Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Omnicell, Inc. trades at 39.5×. Omnicell, Inc. grew revenue faster over the last twelve months: 8.45% against −2.08%. Omnicell, Inc. has the higher net margin (3.13% vs −7.13%) and the higher return on invested capital (3.10% vs −7.62%). Across the 21 metrics below, Omnicell, Inc. leads on 14 and Teladoc Health, Inc. on 7.
Valuation
Profitability
| Metric | OMCL | TDOC | Health Information Services median |
|---|---|---|---|
| Gross margin | 44.77% | 68.97% | 63.38% |
| Operating margin | 4.65% | (7.50%) | (8.35%) |
| Net margin | 3.13% | (7.13%) | (14.70%) |
| Free cash flow margin | 10.17% | 3.56% | 0.58% |
| Return on equity | 3.06% | (12.99%) | (6.82%) |
| Return on assets | 1.89% | (6.28%) | (6.02%) |
| Return on invested capital | 3.10% | (7.62%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack